PO-0752: Isotoxic Intensity Modulated Radiotherapy in stage III NSCLC – A feasibility study

Haslett, K., Ashcroft, L., Bayman, N. et al. (11 more authors) (2018) PO-0752: Isotoxic Intensity Modulated Radiotherapy in stage III NSCLC – A feasibility study. In: Radiotherapy and Oncology. ESTRO 37, 20-24 Apr 2018, Barcelona, Spain. Elsevier , S387-S387.

Metadata

Authors/Creators:
  • Haslett, K.
  • Ashcroft, L.
  • Bayman, N.
  • Franks, K.
  • Groom, N.
  • Hanna, G.
  • Harden, S.
  • Harris, C.
  • Harrow, S.
  • Hatton, M.
  • McCloskey, P.
  • McDonald, F.
  • Ryder, D.
  • Faivre-Finn, C.
Copyright, Publisher and Additional Information: © 2018 Elsevier Ireland Ltd.
Dates:
  • Published (online): 18 June 2018
  • Published: April 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 12 Mar 2019 12:48
Last Modified: 12 Mar 2019 12:48
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/S0167-8140(18)31062-4
Related URLs:

Share / Export

Statistics